Review
doi: 10.1056/NEJMra1001389.
Triple-negative breast cancer
Affiliations
- PMID: 21067385
- DOI: 10.1056/NEJMra1001389
Item in Clipboard
Review
Triple-negative breast cancer
N Engl J Med.
.
Free article
Abstract
Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.
Similar articles
-
Triple-negative breast cancer: current state of the art.Tumori. 2010 Nov-Dec;96(6):875-88. Tumori. 2010. PMID: 21388048 Review.
-
Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.Expert Rev Anticancer Ther. 2010 Feb;10(2):199-207. doi: 10.1586/era.09.189. Expert Rev Anticancer Ther. 2010. PMID: 20131996 Review.
-
What is triple-negative breast cancer?Eur J Cancer. 2008 Dec;44(18):2799-805. doi: 10.1016/j.ejca.2008.09.034. Epub 2008 Nov 12. Eur J Cancer. 2008. PMID: 19008097 Review.
-
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.Clin Cancer Res. 2007 Apr 15;13(8):2329-34. doi: 10.1158/1078-0432.CCR-06-1109. Clin Cancer Res. 2007. PMID: 17438091
-
Pharmacotherapy of triple-negative breast cancer.Expert Opin Pharmacother. 2009 Sep;10(13):2081-93. doi: 10.1517/14656560903117309. Expert Opin Pharmacother. 2009. PMID: 19640211 Review.
Cited by
-
TNFAIP2 promotes HIF1α transcription and breast cancer angiogenesis by activating the Rac1-ERK-AP1 signaling axis.Cell Death Dis. 2024 Nov 13;15(11):821. doi: 10.1038/s41419-024-07223-2. Cell Death Dis. 2024. PMID: 39532855 Free PMC article.
-
PTPN20 promotes metastasis through activating NF-κB signaling in triple-negative breast cancer.Breast Cancer Res. 2024 Nov 6;26(1):155. doi: 10.1186/s13058-024-01910-w. Breast Cancer Res. 2024. PMID: 39506852 Free PMC article.
-
PD-1 inhibitor sintilimab treated patients with metastatic triple-negative breast cancer.Front Cell Dev Biol. 2024 Oct 14;12:1430310. doi: 10.3389/fcell.2024.1430310. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39469113 Free PMC article.
-
Exploring Water-Soluble South African Tulbaghia violacea Harv Extract as a Therapeutic Approach for Triple-Negative Breast Cancer Metastasis.Curr Issues Mol Biol. 2024 Sep 26;46(10):10806-10828. doi: 10.3390/cimb46100642. Curr Issues Mol Biol. 2024. PMID: 39451522 Free PMC article.
-
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.BMJ. 2024 Oct 23;387:e079603. doi: 10.1136/bmj-2024-079603. BMJ. 2024. PMID: 39442958 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
